ABBEY COCUZZA: Open Payments
NPI 1316611254 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 32 payments from 14 companies in 2025. Trend: 2023 $1,116 · 2024 $1,904 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $131 |
| Amgen Inc. | 6 | $96 |
| Alnylam Pharmaceuticals Inc. | 4 | $69 |
| CVRx, Inc. | 2 | $53 |
| SCPHARMACEUTICALS INC. | 2 | $46 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $42 |
| Kestra Medical Technology Services, Inc. | 2 | $28 |
| Boston Scientific Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Wegovy, REPATHA, Barostim Neo System, FUROSCIX, LifeVest, AMVUTTRA, ONPATTRO, Assure WCD.
Industry payments across NJ — which companies pay providers there.
